Health Discovery Corporation (HDVY)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -768 Thousand USD | -149.2% |
| 2019 | 1.56 Million USD | 296.24% |
| 2018 | -795.47 Thousand USD | 8.97% |
| 2017 | -873.88 Thousand USD | 57.76% |
| 2016 | -2.06 Million USD | -252.37% |
| 2015 | -587.06 Thousand USD | -432.35% |
| 2014 | 176.64 Thousand USD | 122.79% |
| 2013 | -774.92 Thousand USD | -75.82% |
| 2012 | -440.73 Thousand USD | 82.54% |
| 2011 | -2.52 Million USD | 64.15% |
| 2010 | -7.04 Million USD | -249.18% |
| 2009 | -2.01 Million USD | 6.08% |
| 2008 | -2.14 Million USD | 20.43% |
| 2007 | -2.69 Million USD | -3.97% |
| 2006 | -2.59 Million USD | 17.83% |
| 2005 | -3.15 Million USD | -43.26% |
| 2004 | -2.2 Million USD | -860.43% |
| 2003 | -229.59 Thousand USD | 35.46% |
| 2002 | -355.76 Thousand USD | -2.68% |
| 2001 | -346.47 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | -504 Thousand USD | 69.96% |
| 2021 FY | - USD | 100.0% |
| 2021 Q1 | -386 Thousand USD | -7.24% |
| 2021 Q2 | -1.67 Million USD | -334.72% |
| 2020 Q4 | -359.95 Thousand USD | -19.99% |
| 2020 FY | -768 Thousand USD | -149.2% |
| 2020 Q2 | 1.41 Million USD | 193.14% |
| 2020 Q1 | -1.51 Million USD | -908.72% |
| 2020 Q3 | -300 Thousand USD | -121.25% |
| 2019 Q4 | -150.29 Thousand USD | 36.58% |
| 2019 FY | 1.56 Million USD | 296.24% |
| 2019 Q2 | 2.12 Million USD | 1300.82% |
| 2019 Q3 | -237 Thousand USD | -111.16% |
| 2019 Q1 | -176.87 Thousand USD | 16.77% |
| 2018 Q3 | -202.65 Thousand USD | -5.69% |
| 2018 FY | -795.47 Thousand USD | 8.97% |
| 2018 Q1 | -188.56 Thousand USD | 0.0% |
| 2018 Q2 | -191.73 Thousand USD | -1.68% |
| 2018 Q4 | -212.51 Thousand USD | -4.86% |
| 2017 FY | -873.88 Thousand USD | 57.76% |
| 2016 FY | -2.06 Million USD | -252.37% |
| 2016 Q4 | -111.18 Thousand USD | 48.85% |
| 2016 Q3 | -217.35 Thousand USD | 59.62% |
| 2016 Q2 | -538.26 Thousand USD | 55.21% |
| 2016 Q1 | -1.2 Million USD | -747.76% |
| 2015 Q1 | -219.09 Thousand USD | -431.75% |
| 2015 FY | -587.06 Thousand USD | -432.35% |
| 2015 Q4 | -141.76 Thousand USD | -163.61% |
| 2015 Q3 | -53.77 Thousand USD | 68.81% |
| 2015 Q2 | -172.42 Thousand USD | 21.3% |
| 2014 Q2 | -12.91 Thousand USD | 83.07% |
| 2014 Q3 | 307.05 Thousand USD | 2477.65% |
| 2014 FY | 176.64 Thousand USD | 122.79% |
| 2014 Q4 | -41.2 Thousand USD | -113.42% |
| 2014 Q1 | -76.29 Thousand USD | -57.88% |
| 2013 Q4 | -48.32 Thousand USD | 91.97% |
| 2013 Q1 | 314.81 Thousand USD | 127.73% |
| 2013 Q3 | -602.01 Thousand USD | -37.01% |
| 2013 Q2 | -439.39 Thousand USD | -239.57% |
| 2013 FY | -774.92 Thousand USD | -75.82% |
| 2012 FY | -440.73 Thousand USD | 82.54% |
| 2012 Q1 | -261.38 Thousand USD | 69.44% |
| 2012 Q3 | 1.48 Million USD | 381.32% |
| 2012 Q2 | -527.26 Thousand USD | -101.72% |
| 2012 Q4 | -1.13 Million USD | -176.54% |
| 2011 Q2 | -209.12 Thousand USD | 74.24% |
| 2011 Q4 | -855.3 Thousand USD | -31.82% |
| 2011 Q3 | -648.85 Thousand USD | -210.27% |
| 2011 FY | -2.52 Million USD | 64.15% |
| 2011 Q1 | -811.66 Thousand USD | 57.88% |
| 2010 Q2 | -2.85 Million USD | -181.87% |
| 2010 FY | -7.04 Million USD | -249.18% |
| 2010 Q3 | -1.22 Million USD | 57.04% |
| 2010 Q4 | -1.92 Million USD | -57.1% |
| 2010 Q1 | -1.01 Million USD | -254.64% |
| 2009 Q4 | -285.63 Thousand USD | 54.14% |
| 2009 Q1 | -557.45 Thousand USD | -18.09% |
| 2009 Q2 | -550.88 Thousand USD | 1.18% |
| 2009 Q3 | -622.88 Thousand USD | -13.07% |
| 2009 FY | -2.01 Million USD | 6.08% |
| 2008 Q3 | -616.4 Thousand USD | -22.73% |
| 2008 Q1 | -556.75 Thousand USD | -0.36% |
| 2008 FY | -2.14 Million USD | 20.43% |
| 2008 Q4 | -472.07 Thousand USD | 23.41% |
| 2008 Q2 | -502.23 Thousand USD | 9.79% |
| 2007 Q2 | -739.29 Thousand USD | -27.66% |
| 2007 FY | -2.69 Million USD | -3.97% |
| 2007 Q4 | -554.75 Thousand USD | 32.82% |
| 2007 Q3 | -825.78 Thousand USD | -11.7% |
| 2007 Q1 | -579.1 Thousand USD | 0.13% |
| 2006 Q3 | -451.88 Thousand USD | 8.38% |
| 2006 Q4 | -579.84 Thousand USD | -28.32% |
| 2006 FY | -2.59 Million USD | 17.83% |
| 2006 Q1 | -1.07 Million USD | -123.82% |
| 2006 Q2 | -493.23 Thousand USD | 53.94% |
| 2005 Q4 | -478.41 Thousand USD | 48.21% |
| 2005 FY | -3.15 Million USD | -43.26% |
| 2005 Q1 | -927.92 Thousand USD | 3.67% |
| 2005 Q2 | -829 Thousand USD | 10.66% |
| 2005 Q3 | -923.68 Thousand USD | -11.42% |
| 2004 Q4 | -963.29 Thousand USD | -78.5% |
| 2004 Q3 | -539.66 Thousand USD | -24.68% |
| 2004 Q2 | -432.82 Thousand USD | -60.73% |
| 2004 Q1 | -269.29 Thousand USD | -134.2% |
| 2004 FY | -2.2 Million USD | -860.43% |
| 2003 Q3 | -55.59 Thousand USD | -93.7% |
| 2003 Q4 | -114.98 Thousand USD | -106.82% |
| 2003 Q2 | -28.7 Thousand USD | 5.31% |
| 2003 FY | -229.59 Thousand USD | 35.46% |
| 2003 Q1 | -30.31 Thousand USD | 68.05% |
| 2002 Q2 | -97.04 Thousand USD | -53.95% |
| 2002 Q4 | -94.85 Thousand USD | 5.92% |
| 2002 Q3 | -100.82 Thousand USD | -3.89% |
| 2002 FY | -355.76 Thousand USD | -2.68% |
| 2002 Q1 | -63.03 Thousand USD | 81.12% |
| 2001 FY | -346.47 Thousand USD | 0.0% |
| 2001 Q3 | -5963.00 USD | 0.0% |
| 2001 Q4 | -333.87 Thousand USD | -5499.03% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Achiko AG | -9.32 Million USD | 100.0% |
| Accelera Innovations, Inc | - USD | NaN% |
| Aspyra Inc. | -5.18 Million USD | 100.0% |
| Cannabis Sativa, Inc. | -1.39 Million USD | 100.0% |
| CompuMed, Inc. | -32.6 Thousand USD | 100.0% |
| CompuGroup Medical SE & Co. KGaA | 45.91 Million USD | 100.0% |
| Cogstate Limited | 5.44 Million USD | 100.0% |
| CareView Communications, Inc. | -3.95 Million USD | 100.0% |
| Craneware plc | 11.7 Million USD | 100.0% |
| Caduceus Software Systems Corp. | -13.96 Million USD | 100.0% |
| Certive Solutions Inc. | -1.67 Million USD | 100.0% |
| Drug Free Solution, Inc. | -1.4 Million USD | 100.0% |
| DATATRAK International, Inc. | 2.65 Million USD | 100.0% |
| Strainsforpains, Inc. | -182.18 Thousand USD | 100.0% |
| Healixa Inc. | -6.73 Million USD | 100.0% |
| Easy Technologies Inc. | - USD | NaN% |
| eWellness Healthcare Corporation | - USD | NaN% |
| Founders Bay Holdings | 7.1 Million USD | 100.0% |
| Healthcare Integrated Technologies, Inc. | -702.48 Thousand USD | 100.0% |
| H-Source Holdings Ltd. | - USD | NaN% |
| InterCare DX, Inc. | -789.33 USD | 100.0% |
| IQ-AI Limited | -623.81 Thousand USD | 100.0% |
| Cannabiz Mobile, Inc. | -750.00 USD | 100.0% |
| Mednow Inc. | -29.48 Million USD | 100.0% |
| Galileo Life Sciences, Inc. | -248.24 Thousand USD | 100.0% |
| MediXall Group, Inc. | -6.83 Million USD | 100.0% |
| Mitesco, Inc. | -13.33 Million USD | 100.0% |
| MobileSmith, Inc. | -14.12 Million USD | 100.0% |
| NantHealth, Inc. | -67.77 Million USD | 100.0% |
| Net Medical Xpress Solutions, Inc. | -1.85 Million USD | 100.0% |
| OneLife Technologies Corp. | - USD | NaN% |
| ORHub, Inc. | -13.38 Million USD | 100.0% |
| Patient Access Solutions, Inc. | -10.59 Million USD | 100.0% |
| Pharma-Bio Serv, Inc. | 1.31 Million USD | 100.0% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 100.0% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | 100.0% |
| Renalytix Plc | -33.45 Million USD | 100.0% |
| Revium Recovery Inc. | -683 Thousand USD | 100.0% |
| RYAH Group, Inc. | - USD | NaN% |
| Carepay Inc. | 313.06 Thousand USD | 100.0% |
| Vaso Corporation | 4.8 Million USD | 100.0% |
| Vynleads, Inc. | -263.43 Thousand USD | 100.0% |